Company / Revenue per Share
AGIOS PHARMACEUTICALS, INC. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.95
FY2025
5-year range
$0.00 / $0.95
FY2021-FY2025
Trend
+44.9%
vs FY2024
Sector context
#105 of 154
Health Care
What the data says
At $0.95, AGIOS PHARMACEUTICALS, INC.'s revenue per share ranks #105 of 154 in the Health Care sector. Revenue per Share has increased for 3 consecutive years, from $0.00 in FY2022 to $0.95 in FY2025.
Based on SEC 10-K filings.
0.95 in FY2025 with a 5-year CAGR of -7.3%.
Improved from $0.49 to $0.95 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -7.3%
- 10-Year CAGR
- -
Sector benchmark
#105 of 154 in Health CareTop 68% of 154This company $0.95 Sector average $10.35
▼
-90.9% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 44.9% year-over-year.
- Ranks #105 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2019.
- Lowest revenue per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.95 | +44.9% |
| FY2024 | $0.65 | +33.9% |
| FY2023 | $0.49 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | -100.0% |
| FY2020 | $1.38 | -31.9% |
| FY2019 | $2.03 | +41.5% |
| FY2018 | $1.43 | +475.1% |
| FY2017 | $0.25 | -86.6% |
| FY2016 | $1.85 | +101.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026